Literature DB >> 25407111

Clinical factors predictive of myelofibrotic evolution in patients with polycythemia vera.

Mario Tiribelli1, Daniela Barraco, Federico De Marchi, Luciana Marin, Marta Medeot, Daniela Damiani, Renato Fanin.   

Abstract

Entities:  

Mesh：

Year:  2014        PMID： 25407111     DOI： 10.1007/s00277-014-2257-z

Source DB:  PubMed          Journal:  Ann Hematol        ISSN： 0939-5555            Impact factor:   3.673


× No keyword cloud information.
  3 in total

Review 1.  Post-ET and Post-PV Myelofibrosis: Updates on a Distinct Prognosis from Primary Myelofibrosis.

Authors:  Francesco Passamonti; Barbara Mora; Daniela Barraco; Margherita Maffioli
Journal:  Curr Hematol Malig Rep       Date:  2018-06       Impact factor: 3.952

2.  Prognostic impact of bone marrow fibrosis in polycythemia vera: validation of the IWG-MRT study and additional observations.

Authors:  D Barraco; S Cerquozzi; C A Hanson; R P Ketterling; A Pardanani; N Gangat; A Tefferi
Journal:  Blood Cancer J       Date:  2017-03-10       Impact factor: 11.037

Review 3.  Blast transformation and fibrotic progression in polycythemia vera and essential thrombocythemia: a literature review of incidence and risk factors.

Authors:  S Cerquozzi; A Tefferi
Journal:  Blood Cancer J       Date:  2015-11-13       Impact factor: 11.037
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.